Laura E. De Wit
Feikje van Stiphout
Sanne A. Groeneveld
Rutger J. Hassink
Douwe Dekker
Citeer dit artikel als
Ned Tijdschr Geneeskd. 2021;165:D5725
Abstract
Abstract
Sluiten
See Also
Psychotropic drugs and QTc prolongation
Assessment of the risk for arrhythmias requires knowledge of QTc interval prolonging drugs and baseline clinical risk factors for QTc prolongation. The combination of both determines whether ECG-monitoring is necessary at the start of a psychotropic drug. In this article, we summarize current literature regarding appropriate methods of calculating the QTc interval, risk factors for QTc prolongation and QTc-prolonging psychotropic drugs.